Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Bladder pain relief by HMGB1 neutralization and soluble thrombomodulin in mice with cyclophosphamide-induced cystitis.

Tanaka J, Yamaguchi K, Ishikura H, Tsubota M, Sekiguchi F, Seki Y, Tsujiuchi T, Murai A, Umemura T, Kawabata A.

Neuropharmacology. 2014 Apr;79:112-8. doi: 10.1016/j.neuropharm.2013.11.003. Epub 2013 Nov 19.

PMID:
24262631
2.

Recombinant human soluble thrombomodulin prevents peripheral HMGB1-dependent hyperalgesia in rats.

Tanaka J, Seki Y, Ishikura H, Tsubota M, Sekiguchi F, Yamaguchi K, Murai A, Umemura T, Kawabata A.

Br J Pharmacol. 2013 Nov;170(6):1233-41. doi: 10.1111/bph.12396.

3.

Involvement of high mobility group box 1 in the development and maintenance of chemotherapy-induced peripheral neuropathy in rats.

Nishida T, Tsubota M, Kawaishi Y, Yamanishi H, Kamitani N, Sekiguchi F, Ishikura H, Liu K, Nishibori M, Kawabata A.

Toxicology. 2016 Jul 15;365:48-58. doi: 10.1016/j.tox.2016.07.016. Epub 2016 Jul 27.

PMID:
27474498
4.

Involvement of the endogenous hydrogen sulfide/Ca(v) 3.2 T-type Ca2+ channel pathway in cystitis-related bladder pain in mice.

Matsunami M, Miki T, Nishiura K, Hayashi Y, Okawa Y, Nishikawa H, Sekiguchi F, Kubo L, Ozaki T, Tsujiuchi T, Kawabata A.

Br J Pharmacol. 2012 Oct;167(4):917-28. doi: 10.1111/j.1476-5381.2012.02060.x.

5.

ONO-8130, a selective prostanoid EP1 receptor antagonist, relieves bladder pain in mice with cyclophosphamide-induced cystitis.

Miki T, Matsunami M, Nakamura S, Okada H, Matsuya H, Kawabata A.

Pain. 2011 Jun;152(6):1373-81. doi: 10.1016/j.pain.2011.02.019. Epub 2011 Mar 10.

PMID:
21396778
6.

Polaprezinc attenuates cyclophosphamide-induced cystitis and related bladder pain in mice.

Murakami-Nakayama M, Tsubota M, Hiruma S, Sekiguchi F, Matsuyama K, Kimura T, Moriyama M, Kawabata A.

J Pharmacol Sci. 2015 Feb;127(2):223-8. doi: 10.1016/j.jphs.2015.01.004. Epub 2015 Jan 28.

7.

Macrophage-derived HMGB1 as a Pain Mediator in the Early Stage of Acute Pancreatitis in Mice: Targeting RAGE and CXCL12/CXCR4 Axis.

Irie Y, Tsubota M, Ishikura H, Sekiguchi F, Terada Y, Tsujiuchi T, Liu K, Nishibori M, Kawabata A.

J Neuroimmune Pharmacol. 2017 Jul 28. doi: 10.1007/s11481-017-9757-2. [Epub ahead of print]

PMID:
28755135
8.

Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1.

Kouzoukas DE, Ma F, Meyer-Siegler KL, Westlund KN, Hunt DE, Vera PL.

PLoS One. 2016 Mar 24;11(3):e0152055. doi: 10.1371/journal.pone.0152055. eCollection 2016.

9.

Effect of tramadol on pain-related behaviors and bladder overactivity in rodent cystitis models.

Oyama T, Homan T, Kyotani J, Oka M.

Eur J Pharmacol. 2012 Feb 15;676(1-3):75-80. doi: 10.1016/j.ejphar.2011.12.002. Epub 2011 Dec 14.

PMID:
22197002
10.

Recombinant human soluble thrombomodulin ameliorates cerebral ischemic injury through a high-mobility group box 1 inhibitory mechanism without hemorrhagic complications in mice.

Nakamura Y, Nakano T, Irie K, Sano K, Tanaka J, Yamashita Y, Satho T, Matsuo K, Fujioka M, Ishikura H, Mishima K.

J Neurol Sci. 2016 Mar 15;362:278-82. doi: 10.1016/j.jns.2016.01.047. Epub 2016 Jan 22.

PMID:
26944163
11.

Receptor for advanced glycation end products and its ligand high-mobility group box-1 mediate allergic airway sensitization and airway inflammation.

Ullah MA, Loh Z, Gan WJ, Zhang V, Yang H, Li JH, Yamamoto Y, Schmidt AM, Armour CL, Hughes JM, Phipps S, Sukkar MB.

J Allergy Clin Immunol. 2014 Aug;134(2):440-50. doi: 10.1016/j.jaci.2013.12.1035. Epub 2014 Feb 4.

PMID:
24506934
12.

Systemic involvement of high-mobility group box 1 protein and therapeutic effect of anti-high-mobility group box 1 protein antibody in a rat model of crush injury.

Shimazaki J, Matsumoto N, Ogura H, Muroya T, Kuwagata Y, Nakagawa J, Yamakawa K, Hosotsubo H, Imamura Y, Shimazu T.

Shock. 2012 Jun;37(6):634-8. doi: 10.1097/SHK.0b013e31824ed6b7.

PMID:
22392147
13.

High mobility group box 1 promotes small intestinal damage induced by nonsteroidal anti-inflammatory drugs through Toll-like receptor 4.

Nadatani Y, Watanabe T, Tanigawa T, Machida H, Okazaki H, Yamagami H, Watanabe K, Tominaga K, Fujiwara Y, Arakawa T.

Am J Pathol. 2012 Jul;181(1):98-110. doi: 10.1016/j.ajpath.2012.03.039. Epub 2012 May 22.

PMID:
22634181
14.

Disulfide high mobility group box-1 causes bladder pain through bladder Toll-like receptor 4.

Ma F, Kouzoukas DE, Meyer-Siegler KL, Westlund KN, Hunt DE, Vera PL.

BMC Physiol. 2017 May 25;17(1):6. doi: 10.1186/s12899-017-0032-9.

15.

Spinal HMGB1 induces TLR4-mediated long-lasting hypersensitivity and glial activation and regulates pain-like behavior in experimental arthritis.

Agalave NM, Larsson M, Abdelmoaty S, Su J, Baharpoor A, Lundb├Ąck P, Palmblad K, Andersson U, Harris H, Svensson CI.

Pain. 2014 Sep;155(9):1802-13. doi: 10.1016/j.pain.2014.06.007. Epub 2014 Jun 20.

PMID:
24954167
16.

Brain-derived neurotrophic factor, acting at the spinal cord level, participates in bladder hyperactivity and referred pain during chronic bladder inflammation.

Frias B, Allen S, Dawbarn D, Charrua A, Cruz F, Cruz CD.

Neuroscience. 2013 Mar 27;234:88-102. doi: 10.1016/j.neuroscience.2012.12.044. Epub 2013 Jan 8.

PMID:
23313710
17.

Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene.

Laird JM, Olivar T, Roza C, De Felipe C, Hunt SP, Cervero F.

Neuroscience. 2000;98(2):345-52.

PMID:
10854767
18.

Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice.

Laird JM, Souslova V, Wood JN, Cervero F.

J Neurosci. 2002 Oct 1;22(19):8352-6.

19.

Lack of TRPV1 inhibits cystitis-induced increased mechanical sensitivity in mice.

Wang ZY, Wang P, Merriam FV, Bjorling DE.

Pain. 2008 Sep 30;139(1):158-67. doi: 10.1016/j.pain.2008.03.020. Epub 2008 Apr 28.

PMID:
18445509
20.

Role of CXCR2 and TRPV1 in functional, inflammatory and behavioural changes in the rat model of cyclophosphamide-induced haemorrhagic cystitis.

Dornelles FN, Andrade EL, Campos MM, Calixto JB.

Br J Pharmacol. 2014 Jan;171(2):452-67. doi: 10.1111/bph.12467.

Supplemental Content

Support Center